Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

23.67
Delayed Data
As of Oct 19
 -0.64 / -2.63%
Today’s Change
11.41
Today|||52-Week Range
25.02
+92.91%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close24.31
Today’s open24.25
Day’s range23.03 - 24.25
Volume1,801,643
Average volume (3 months)1,119,487
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book42.27

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-0.70-0.69%
ONCESpark Therapeutics I...-1.21-1.48%
XONIntrexon Corp-0.02-0.11%
JUNOJuno Therapeutics In...+0.32+0.74%
Data as of 4:00pm ET, 10/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts